Zelda Therapeutics Partners with St. Vincent’s to Study Opioid Use Reduction

In a focused effort to study the potential impact cannabinoid-based medical interventions may have on reducing opioid use for pain reduction, Perth-based Zelda Therapeutics LTD has established a partnership with St. Vincent’s Hospital in Melbourne to conduct clinical trials to study potential uses for these treatments. Subjects who have become dependent on opioids for pain management comprise the target group for these trials.

Managing director Dr Richard Hopkins said:

“While similar studies have been conducted in other countries with promising results, we believe that local medical community participation in these studies will accelerate acceptance of the potential of cannabinoid-based medicines.”

Read more.

Leave a Reply